Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
327 hedge funds and large institutions have $7.66B invested in Immunogen Inc in 2023 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 71 increasing their positions, 101 reducing their positions, and 69 closing their positions.
218% more funds holding in top 10
Funds holding in top 10: 11 → 35 (+24)
96% more capital invested
Capital invested by funds: $3.91B → $7.66B (+$3.75B)
77% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 69
64% more call options, than puts
Call options by funds: $225M | Put options by funds: $138M
19% more funds holding
Funds holding: 275 → 327 (+52)
30% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 101
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$208M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$113M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$107M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$69.4M |
| 5 |
Morgan Stanley
New York
|
+$67.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$225M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$132M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$106M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$56.1M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$54.4M |
IMGN Hedge Fund Activity: Q4 2023 in Review
327 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2023, worth a combined $7.66B — up 96% from $3.91B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new IMGN positions and 69 closed out — a net gain of 53 holders — while 71 added to existing stakes and 101 trimmed.
The largest buyer was RA Capital Management, adding an estimated $208M. The largest seller was Wellington Management Group, cutting an estimated $225M.
- 327 institutional investors held Immunogen Inc (IMGN) as of Q4 2023, up from 275 in Q3 2023.
- Funds reported $7.66B of Immunogen Inc stock for Q4 2023, up 96% quarter-over-quarter.
- 122 funds opened new Immunogen Inc positions in Q4 2023 and 69 closed out, a net change of +53 holders.
- The largest Immunogen Inc buyer in Q4 2023 was RA Capital Management, an estimated $208M added.
- The largest Immunogen Inc seller in Q4 2023 was Wellington Management Group, an estimated $225M sold.
Based on aggregated 13F filings for Q4 2023.